Daily Stock List
SolarWorld AG (SRWRY)
Green Chip Review reported previously on SolarWorld AG (SRWRY), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
SolarWorld AG is a solar power technology company whose shares trade on the OTC Market's OTC Pink Current Information. The Company engages in the photovoltaic power generation business around the world. SolarWorld's operations involve research, development, production, and recycling along the entire solar value chain, from silicon via crystallization, wafer, cell, and module production. SolarWorld has their corporate headquarters in Bonn, Germany. Their U.S. headquarters is in Hillsboro, Oregon.
The Company operates four vertically integrated business segments. These are the production of silicon wafers (wafer production) by Deutsche Solar AG; the production of solar cells (cell production) by Deutsche Cell GmbH; the production of solar modules (module production) by Gaellivare PhotoVoltaic AB and Solar Factory GmbH; and trade in solar modules (merchandise) by SolarWorld AG.
SolarWorld offers products ranging from crystalline silicon ingots, wafers, cells and panels for grid-tied and off-grid power generation. The main building blocks are high-performance monocrystalline and polycrystalline SolarWorld Sunmodule™ solar panels and custom-designed Sunkits® solar systems.
SolarWorld operates factories in the United States and Germany as well as sales offices in all of the world's solar markets. SolarWorld has approximately 2,700 employees. The SolarWorld group is one of the world's largest solar energy businesses, and the largest U.S. solar panel manufacturer for over 35 years.
In Hillsboro, Oregon, SolarWorld operates the equivalent of four production plants on a 97-acre campus, maintaining 500 megawatts worth of photovoltaic production capacity. Production from that site supplies demand in the U.S., Canada and Latin America. Their Camarillo, California location houses the Company's commercial hub, providing sales, marketing and distribution for all three markets in the Americas.
SolarWorld also has their Installer Program. The SolarWorld installer program assists companies in growing their businesses. The program is for businesses of all sizes. The Company's Authorized Installer program is a way for businesses to expand their already established solar businesses. SolarWorld's Registered Installer program is a way for electricians and other contractors to begin selling solar and provide a competitive solution in the marketplace.
SolarWorld AG (SRWRY), closed Friday's trading session at $0.98, up 34.62%, on 100 volume with 1 trade. The average volume for the last 60 days is 342 and the stock's 52-week low/high is $0.58/$2.88.
Neah Power Systems, Inc. (NPWZ)
Agoracom reported recently on Neah Power Systems, Inc. (NPWZ), MoneyTV, OTCPicks, PennyDreamers, FeedBlitz, SmallCapVoice did earlier, and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.
Listed on the OTC Bulletin Board, Neah Power Systems, Inc. is a developer of long-lasting, efficient and safe power solutions. These solutions are for the military, transportation, and portable electronics applications. The Company utilizes a unique, patented and award winning, silicon-based design for their Powerchip™ micro fuel cells that enable higher power densities, lower cost and compact form-factors.
Founded in 1999, Neah Power Systems is based in Bothell, Washington. A publicly held company, original venture investors include Frazier Technology Ventures, Alta Partners, Intel Capital, Castile Ventures and WestAM.
The Company's previous awards include the 2012 ZINO Green finalist, the 2010 WTIA finalist, and 2010 Best of What's New™ Popular Science and other awards. Neah Power Systems' micro fuel cell system can run in aerobic and anaerobic modes.
This past September, the Company announced that they shipped revenue-generating product to a Fortune 150 US Defense Supplier against a previously announced purchase order for the Company's PowerChip™ fuel cell.
The defense supplier is exploring the use of Neah's Powerchip™ fuel cell for an array of applications. These include soldier power, remote power stations, and unmanned underwater and aerial vehicles. Neah anticipates broader adoption in 2013.
In October 2012, Neah Power Systems announced that they developed PowerPlay™; a consumer oriented fuel cell recharging solution slated for full release in Spring 2013. Using their larger PowerChip™ silicon based fuel cell processing expertise; they developed PowerPlay™. This is a lightweight, portable fuel cell recharger designed for cell phones, smart phones, tablets or almost any portable consumer device.
The PowerPlay™ features a small fuel cell without any of the pumps or moving parts found in the Company's larger PowerChip™ products. These passive fuel cells use small interchangeable, refillable cartridges to provide the fuel. The expectation is that each cartridge will supply enough power to charge a typical smart phone up to four times.
Neah Power Systems, Inc. (NPWZ), closed Friday's trading session at $0.008, up 1.27%, on 1,291,874 volume with 23 trades. The average volume for the last 60 days is 510,424 and the stock's 52-week low/high is $0.005/$0.026.
Kallo, Inc. (KALO)
StockLockandLoad, StockBomb.com, StockRockandRoll, and PennyStockLocks.com reported earlier on Kallo, Inc. (KALO), and today we highlight the Company, here at the QualityStocks Daily Newsletter.
Kallo, Inc., a development stage company, is a medical information enterprise with corporate headquarters in Markham, Ontario. The Company's domain expertise is Healthcare, Telecommunications, and Education and Training. They have a presence in Canada and the United States. The Company formerly went by the name Diamond Technologies, Inc. They changed their name to Kallo, Inc. in January 2011. Founded in 2006, Kallo's shares trade on the OTCBB.
The Company uses technology to assist physicians and healthcare providers to streamline patient information in a coherent and usable manner. The design of Kallo's software is to take patient medical information from several sources and deposit it into a single source as electronic medical records (EMR) for each patient. The Company has early stage products for which they plan to evaluate partnership opportunities to further develop and commercialize them. These products are in addition to their EMR product.
Kallo's plan and focus during the coming months include selling their existing product, developing, and possibly selling new products. Their intention is to initiate sales of their products in their target commercial areas. The Company's target commercial areas are hospitals, clinics and doctors' offices. Kallo expects to concentrate on marketing their present offering as well as completing product development for their product candidates to increase their possibilities for current and future revenue generation.
In addition to their EMR, which is ready for production, Kallo has prioritized two products for completion of development. One is C&ID-IMS. This is their Communicable and Infectious Diseases Information Management System technology. The second is CCG - their Clinical-Care Globalization technology.
In November 2012, Kallo reported that at the earlier held Practical Pediatrics Ontario Conference on November 9 and 10, 2012, Kallo introduced EMCURx PEMR. This is an electronic medical record system. It was specially customized for pediatric practices and workflows; it was recommended by the Pediatrics Section, Ontario Medical Association (OMA) as the EMR of choice that Ontario Pediatricians should strongly consider for their practices. There are approximately 1200 pediatricians in Ontario. Until now, many were hesitant to adopt EMR for their practices because of a lack of suitable products.
Kallo, Inc. (KALO), closed Friday's trading session at $0.03, up 30.43%, on 30,800 volume with 4 trades. The average volume for the last 60 days is 79,148 and the stock's 52-week low/high is $0.01/$0.51.
Worlds, Inc. (WDDD)
We are highlighting Worlds, Inc. (WDDD), here at the QualityStocks Daily Newsletter.
Headquartered in Brookline, Massachusetts, Worlds, Inc. is an intellectual property (IP) developer and licensee of patents related to 3D online virtual worlds and interactive communication. The Company creates or acquires complementary digital media technologies and patents that expand the features, versatility and reach of their technology. The Company formerly went by the name Worlds.com, Inc. They changed their name to Worlds, Inc. on February 14, 2011. Founded in 1994, Worlds' shares trade on the OTC Bulletin Board.
Worlds is the innovative platform in 3D virtual communities and rich immersive environments. The Company creates their own Internet sites and sites available by way of third party online service providers. The Company's technology enables the development of virtual worlds, which have diverse applications. These include a virtual meeting place, such as a fan club; a 3D e-commerce store to view merchandise in 3D and purchase it online; and a virtual classroom to view content through video streaming and then discuss about the content in real time. Additionally, the Company operates Worlds Ultimate 3D Chat. This is a proprietary online 3D Internet chat site for the music industry and fans.
Worlds leverages their patented proprietary technology in collaboration with brand leaders in specific market segments to offer members multi-user environments that have interactive Avatars, rich media graphics, text chat, voice-to-voice chat, video and e-commerce. The 3D communities allow visitors to interact with each other, teleport throughout the Worlds environment and participate in shared experiences. Worlds also encourages individuals to create their own virtual spaces, communities and unique Avatars with user-friendly tools.
In May 2012, the Company announced that they were issued Patent No. 8,161,385 from the U.S. Patent & Trademark Office (USPTO) titled "System and Method for Enabling Users to Interact in a Virtual Space." This is the seventh patent in Worlds' IP portfolio. The patent relates to computer architecture for three-dimensional graphical multi-user interactive virtual world systems for applications such as 3-D massive multi-player online role-playing games (MMO or MMORPG).
This past September, Worlds reported that U.S. District Judge Denise J. Casper established a schedule for upcoming hearings and other case deadlines in Worlds, Inc. vs. Activision Blizzard, Inc., Blizzard Entertainment, Inc. and Activision Publishing, Inc. (Activision Blizzard, Inc. et al) in Civil Action No, 1:12-CV-10576(DJC). This is a patent infringement lawsuit filed by Worlds on March 30, 2012 in the United States District Court for the District of Massachusetts.
The patent claim construction hearing (a Markman hearing) is set for June 27, 2013. At this time, the judge will be asked to issue rulings regarding the language and interpretation of the Worlds patents at issue in the case. The Markman ruling will define the property rights for the technologies that Worlds has invented and has the right to exclusively practice. The court's Markman hearing decisions will drive and inform many aspects of the litigation. Markman hearings are considered a critical event in a patent lawsuit.
Worlds, Inc. (WDDD), closed Friday's trading session at $0.23, up 9.52%, on 1,038,599 volume with 146 trades. The average volume for the last 60 days is 94,002 and the stock's 52-week low/high is $0.055/$0.36.
Attitude Drinks, Inc. (ATTD)
OTCPicks and SmallCapVoice reported this week on Attitude Drinks, Inc. (ATTD), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Based in Palm Beach Gardens, Florida, Attitude Drinks, Inc. is a beverage brand development company whose shares trade on the OTC Bulletin Board. The Company has a pure milk recovery drink that exploits recent scientific evidence confirming the benefits of milk and protein as an exercise recovery aid. Attitude Drinks focuses on delivering experiential, functional and healthful beverages. They have developed their Phase III® Recovery beverage. The Phase III® Recovery product is a milk-based protein drink; it is primarily for active sports minded males and females from ages 15 to 35.
Phase III® Recovery sells in select local, regional and national markets, including colleges, universities, convenience stores, fitness centers and gyms, as well as online. The product is a reduced sugar, low fat, real flavored milk. It features 29 percent less sugar and more than two times the protein of regular chocolate milk. Phase III® Recovery has a 12-month shelf life (unrefrigerated).
Attitude Drinks filtered out the lactose and much of the sugar naturally found in low fat milk. Phase III® has no protein added. The concentrated mineral and nutrient rich milk provides 35 grams of protein and the taste and mouth feel of low fat chocolate milk. This process enables strategically balanced protein and carbohydrate levels and fortification with a strong list of nutrients and electrolytes. Phase III® is packaged in 14.5-ounce re-sealable, environmentally "green" bottles.
In November 2012, the Company announced a sales authorization with The Kroger Co., headquartered in Cincinnati, Ohio. Phase III® will be available in select grocery stores through Kroger in Alabama, Georgia, Tennessee, South Carolina and Kentucky.
In early December, Attitude Drinks announced a sales authorization for Phase III® Recovery with Daily's Convenience Stores. Daily's has 80 locations in middle Tennessee and Kentucky. Det Distribution is handling Phase III® through their two distribution centers in Kentucky, and The Hand Family Distributors is carrying Phase III® through their five service outlets, two in Kentucky and three in Tennessee.
Attitude Drinks, Inc. (ATTD), closed Friday's trading session at $0.0003, even for the day, on 16,798,662 volume with 25 trades. The average volume for the last 60 days is 56,924,997 and the stock's 52-week low/high is $0.0001/$0.0093.
Gold Reach Resources Ltd. (GRV.V)
We are highlighting Gold Reach Resources Ltd. (GRV.V), here at the QualityStocks Daily Newsletter.
Headquartered in Vancouver, British Columbia (BC), Gold Reach Resources Ltd. is a mineral exploration and development company that lists on the TSX Venture Exchange. The Company focuses on advancing their large Ootsa Cu-Au porphyry deposit in BC. They have made a Copper (Cu) Gold (Au) Molybdenum (Mo) discovery on their 100 percent held Ootsa Property located adjacent to the 16,000 tonne per day Huckleberry Mine currently producing Cu Au and Mo in central BC. The Ootsa property is an advanced stage exploration project containing the Seel and Ox porphyry systems both with compliant resource estimates wide open for expansion.
Gold Reach Resources has recently added the discovery of the West Seal Porphyry. Here, Drill Hole S12-101 encountered 194 meters of higher-grade mineralization grading 0.71 percent Cu Eq. consisting of 0.22 percent Cu, 0.47 g/t Au, 0.04 percent Mo and 1.85 g/t Ag within a much larger 817 meter interval grading 0.45 percent Cu Eq. consisting of 0.20 percent Cu, 0.21 g/t Au, 0.026 percent Mo and 2.24 g/t Ag from 262 meters to the end of the hole at 1,079 meters.
The Seel porphyry contains a NI 43-101 compliant resource containing 214.78 million tonnes grading 0.33 percent Cu Eq. consisting of 0.17 percent Cu, 0.13 g/t Au, 0.017 percent Mo, and 2.17 g/t Ag in the inferred category plus an additional 28.13 million tonnes grading 0.40 percent Cu Eq. consisting of 0.22 percent Cu and 0.21 g/t Au in the indicated category. The Ox porphyry, located 4 km northeast of Seel, contains a NI43-101 compliant resource containing 16 million tonnes grading 0.3 percent Cu and 0.04 percent Mo in the inferred category.
Yesterday, Gold Reach Resources announced that assay results for the final eight holes drilled into the Ox porphyry during the 2012 drill program were received. The Ox porphyry is 4 kilometers north-northeast of the Company's West Seel discovery. Both deposits occur on the Company's 100 percent owned Ootsa Property.
Ox highlights include the encountering of strong mineralization; higher grades near surface, and significant expansion potential. In 2012, 4947.4 meters in 18 holes were drilled at the Ox deposit. This drilling will be added to the previous drilling data from the zone and will be used in an updated resource calculation that will begin soon.
Gold Reach Resources holds a two percent Net Smelter Return (NSR) covering 23,000 hectares of mining claims located adjacent to the Blackwater Gold deposit in central British Columbia.
Gold Reach Resources Ltd. (GRV.V), closed Friday's trading session at $1.26, down 2.33%, on 9,800 volume. The stock's 52-week low/high is $0.47/$2.13.
CYBRA Corp. (CYRP)
PennyStockScholar, OTCtipReporter, M2 Communications, and FeedBlitz reported previously on CYBRA Corp. (CYRP), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.
CYBRA Corp. is a software developer and systems integrator specializing in bar code, RFID, forms, and web-based solutions. The Company is the developer of award-winning MarkMagic Bar Code Labels, RFID Tags, and Electronic Forms Software and EdgeMagic Integrated RFID Control Software. CYBRA software products run on the IBM System i (AS/400, iSeries), Linux and Windows servers. The Company lists on the OTCBB. Founded in 1985, CYBRA has their corporate headquarters in Yonkers, New York.
CYBRA is an IBM Business Partner and Motorola/Symbol Partner. A network of value added resellers throughout the United States represents CYBRA. The Company has global sales and support offices.
The Company sells their products mainly through Original Equipment Manufacturers (OEMs). CYBRA's flagship product, MarkMagic, is a bar code, radio frequency identification (RFID) and forms middleware solution, which enables customers to integrate bar code labels, RFID technology, and electronic forms into their business systems.
In addition, CYBRA offers EdgeMagic (first released in February 2008), an integrated RFID control solution to manage edge readers and analog control devices. The Company also offers commission, read, filter, and verify RFID tags to comply with electronic product code compliance mandates, as well as for asset tracking applications and integration with ERP and warehouse management application packages.
In July 2012, CYBRA released the findings of the Company's latest customer survey on RFID trends. The survey results show an upward trend in the adoption of RFID technology. The Company conducted their first RFID Survey in 2008, in which only 21 percent of companies stated that they use RFID technology.
According to the latest survey, 54 percent of organizations are using, piloting, or already in the process of implementing RFID technology. According to the recent survey, 81 percent of respondents expect to achieve their Return on Investment (ROI) in three years or less, up from 72 percent in the previous survey.
CYBRA Corp. (CYRP), closed Friday's trading session at $0.095, up 18.75%, on 5,202 volume with 2 trades. The average volume for the last 60 days is 2,850 and the stock's 52-week low/high is $0.03/$0.25.
Santacruz Silver Mining Ltd. (SCZ.V)
Today we are reporting on Santacruz Silver Mining Ltd. (SCZ.V), here at the QualityStocks Daily Newsletter.
Santacruz Silver Mining Ltd. is a Mexican focused silver company whose shares trade on the TSX Venture Exchange. The Company has a project in development (Rosario) and two advanced-stage exploration projects (San Felipe and Gavilanes). Santacruz's corporate objective is to become a mid-tier silver producer. A technical team of professionals with proven records of accomplishment in developing, operating and discovering silver mines in Mexico manages the Company. Santacruz Silver Mining has their headquarters in Vancouver, British Columbia.
The expectation is that the Company's Rosario Project will reach production by the end of the first quarter of 2013. Recently, Santacruz Silver Mining announced the completion of an updated NI 43-101 mineral resource estimate on their Rosario Project in the Charcas Mining District, San Luis Potosi, Mexico. The measured and indicated silver equivalent (AgEq) resource amounts to 10.2 million AgEq ounces; the inferred resources stand at 2.5 million AgEq ounces.
The initial resource estimate at the Rosario Project included only inferred resources. Subsequent exploration work performed at the property by the Company has successfully upgraded 86 percent of these inferred resources to measured and indicated. The mineral resource estimate was completed by Gustavson Associates, LLC, of Lakewood, Colorado.
This week, Santacruz Silver Mining announced that they filed on SEDAR an updated technical report concerning their San Felipe Project, titled "Update of NI 43-101 Technical Report on Resources, San Felipe Project, Sonora, Mexico". The updated report provides additional information on data verification and sampling. It is updated as of December 19, 2012, and has an effective date of April 5, 2012. The resources remain unchanged from the original report that was announced on July 16, 2012.
Furthermore, the Company announced that they filed on SEDAR a technical report concerning their Rosario Project, titled "NI 43-101 Technical Report on Resources, Rosario Project, San Luis Potosi, Mexico". They announced a new resource estimate on their Rosario Project in a news release dated December 21, 2012, which new resource estimate lead to this report. The report is dated December 19, 2012 with an effective date of December 1, 2012.
Santacruz Silver Mining Ltd. (SCZ.V), closed Friday's trading session at $2.10, even with yesterday's close, on 48,400 volume. The stock's 52-week low/high is $0.80/$2.50.
Cardium Therapeutics, Inc. (CXM)
The QualityStocks Daily Newsletter would like to spotlight Cardium Therapeutics, Inc. (CXM). Today, Cardium Therapeutics, Inc. closed trading at $0.1925, off by 5.17%, on 104,831 volume with 49 trades. The stock’s average daily volume over the past 60 days is 209,412, and its 52-week low/high is $0.17/$0.42.
Cardium Therapeutics, Inc. was excited to announce today that company Chairman and CEO, Christopher J. Reinhard, will be on hand to provide venue-goers at this year's extremely influential Biotech Showcase 2013 Conference with a comprehensive corporate overview and in-depth look at the recent entrepreneurial initiatives this biotech pioneer in health sciences and regenerative medicine has undertaken, this coming Monday, January 7th, 2:15 pm (PST), at the luxurious Parc 55 Wyndham San Francisco Union Square Hotel. Mr. Reinhard will cover internally developed, strategic partner-enabled product and platform opportunities related to the commercialization of Excellagen, as well as the clinical development of Genedexa™, the first natural pipeline extension to the FDA-cleared Excellagen® platform, a DNA-based Phase 2b/3 product candidate initially for the treatment of chronic, non-healing diabetic foot ulcers.
Cardium Therapeutics, Inc. (CXM) is a health sciences and regenerative medicine company focused on acquiring and strategically developing new and innovative products and businesses to address significant unmet medical needs. Comprised of large-market opportunities with definable pathways to commercialization, partnering, and other economic monetizations, Cardium's current portfolio includes the Tissue Repair Company, Cardium Biologics, and the company's in-house MedPodium Health Sciences healthy lifestyle product platform.
The company's lead commercial product Excellagen® topical gel for wound care management recently received FDA clearance for marketing and sale in the United States. In addition to plans to advance the product's commercialization in the U.S. and internationally via strategic partnerships, the company plans to develop new product extensions for additional wound healing applications and is working towards securing approval for marketing and sale in South Korea and through the CE Mark application process in the European Union.
Generx®, Cardium's lead clinical development product candidate, is a DNA-based angiogenic biologic designed to treat patients with myocardial ischemia due to coronary artery disease. Cardium recently initiated its Generx Phase 3 / registration study in Russia. Consistent with its capital-efficient business model, Cardium is also actively evaluating new technologies and business opportunities. The company utilizes its team's skills in late-stage product development to bridge the critical gap between promising new technologies and product opportunities that are ready for commercialization.
Cardium is dedicated to building on its core products and product candidates to continually create new opportunities for greater success. Leveraging the advantages of its capital-efficient, asset-based business strategy, the company provides a diversified and more balanced portfolio of risk/return opportunities with the chief objective of providing long-term shareholder value. Disclaimer
Cardium Therapeutics, Inc. Company Blog
Cardium Therapeutics, Inc. News:
Cardium To Present At Biotech Showcase 2013 Investment Conference And Report On New Cardium Initiatives
Cardium Announces Sales and Distribution Agreement With Academy Medical to Promote Excellagen Clinical Adoption by U.S. Government Medical Providers
Cardium Announces Patent Award For Rights To Gene Therapy for Coronary Heart Disease, Resolves Long-standing IP Competition
Consorteum Holdings, Inc. (CSRH)
The QualityStocks Daily Newsletter would like to spotlight Consorteum Holdings, Inc. (CSRH). Today, Consorteum Holdings, Inc. closed trading at $0.016, up 33.33%, on 214,000 volume with 7 trades. The stock’s average daily volume over the past 60 days is 130,007, and its 52-week low/high is $0.001/$0.018.
Consorteum Holdings, Inc. (CSRH) utilizes the most technically advanced global solutions available today. By working with a multitude of global technologies, Consorteum is able to create customized programs for maximum results. This approach enables unparalleled flexibility when sourcing solutions, resulting in smarter, faster deployment of technologies, competitive pricing, and potential for new streams of revenue.
Through its exclusive software license with Tarsin Inc., the company leverages a team of software developers that understands the complexities of delivering digital media content across mobile handsets. Tarsin is capable of providing clients with integration and support for over 700 mobile carriers globally on a seamless and secure platform to take advantage of the increasing demand for rich mobile content.
Consorteum's flagship CAPSA technology platform brings a universal solution to the problems of wagering and betting on mobile devices. Multiple different operating systems, user interfaces, and form factors have created enormous barriers to launching commercial initiatives. But with CAPSA, gaming operators can now cost-effectively monetize innovative mobile wagering products and services quickly and robustly.
In addition to its mobile initiatives, Consorteum is also actively engaged in the financial industry, providing MasterCard solutions as well as loyalty and reward programs. The company has strategically designed its business initiatives to create repetitive transactions on an ongoing basis. Consorteum's goal is to have their customers think of them more as partners, rather than just technology providers, for longer-lasting, more profitable relationships. Disclaimer
Consorteum Holdings, Inc. Company Blog
Consorteum Holdings, Inc. News:
Consorteum Holdings Files Form 10-K Report With the Securities and Exchange Commission
CORRECTION -- Tarsin, a Leader in Secure Mobile Platform Technology, Forges New Frontiers in Mobile Gaming
Tarsin, a Leader in Secure Mobile Platform Technology, Forges New Frontiers in Mobile Gaming
TNI BioTech, Inc. (TNIB)
The QualityStocks Daily Newsletter would like to spotlight TNI BioTech, Inc. (TNIB). Today, TNI BioTech, Inc. closed trading at $9.19, up 0.44%, on 23,976 volume with 48 trades. The stock’s average daily volume over the past 60 days is 31,156, and its 52-week low/high is $0.72/$10.01.
TNI BioTech, Inc. (TNIB) is focused on utilizing patented immunotherapy to activate and mobilize the body's immune system to combat fatal diseases. The company's products and technologies improve the treatment and diagnosis of cancer, infections such as HIV/AIDS, and autoimmune diseases. Future initiatives include treatment for multiple sclerosis, herpes viral infections, and other conditions that result in altered-immune response.
The company's product portfolio currently includes IRT-101, an active immunotherapy that works by activating a patient's immune system against infectious diseases and tumor cells; IRT-102, an adaptive immunotherapy that works by isolating and enriching a patient's own immune cells; and IRT-103, an active immunotherapy that works by activating a patient's immune system against HIV/AIDS and tumor cells.
Leveraging the advantages of today's cutting-edge treatment options, the company aims to meet the growing demand for quality healthcare with safer, more effective radiation therapy; new-targeted drug therapies; and minimally invasive surgical alternatives around the world. TNI BioTech most recently signed a letter of intent to open clinics in Africa that will provide advanced treatment for cancer, HIV/AIDS, and autoimmune diseases.
The company plans to continue clinical trials in China during 2012 and 2013, and anticipates starting trials in the United States by early 2013.The company is also in negotiations to acquire a number of other immunotherapy products, patents, and therapies. Led by a management team with decades of experience and solid business plan, TNI BioTech is poised to improve healthcare with active and adaptive forms of improved immunotherapies. Disclaimer
TNI BioTech, Inc. Company Blog
TNI BioTech, Inc. News:
TNI BioTech to Present at 6th Annual OneMedForum San Francisco 2013
Umbrella Research Initiates Coverage on TNI BioTech
TNI BioTech, Inc. Signs Exclusive Distributor Agreement for Federal Republic of Nigeria with G-Ex Technologies/St. Maris Pharma & GB Pharma Holdings LLC
Viscount Systems, Inc. (VSYS)
The QualityStocks Daily Newsletter would like to spotlight Viscount Systems, Inc. (VSYS). Today, Viscount Systems, Inc. closed trading at $0.067, off by 1.47%, on 15,000 volume with 2 trades. The stock’s average daily volume over the past 60 days is 55,002, and its 52-week low/high is $0.0069/$0.07.
Viscount Systems, Inc. (VSYS) designs, manufactures, and services access control and security products such as door access control systems and emergency communications systems. The company's products have been installed in approximately 35,000 sites in over 30 countries, including prisons, schools, hospitals, and corporate offices.
Designing security systems since 1969, the company has developed strategic working relationships with leading equipment vendors to support its continued profitability and growth. Viscount has been consistently profitable for nearly 15 years and currently generates annual revenues of approximately $5 million.
Five hundred dealers help distribute Viscount's existing products throughout North America. This distribution network is not static as the company constantly pursues additional sales channels. Products are advertised in various print publications and regularly displayed at tradeshows as well. Direct marketing via training seminars also helps drive sales.
Viscount's management team has more than 60 years of combined experience in the development and production of electronic door control and telecommunication systems. Under this leadership, the SIA Convergence Solution of the Year accolade and Platinum Award for Emergency Response and Gold Award for Access Control at the Government Security Awards (GOVSEC) for 2011 have been presented to the company. Disclaimer
Viscount Systems, Inc. Company Blog
Viscount Systems, Inc. News:
SoundView Technology Group Issues Research Report on Viscount Systems
Viscount Systems Appoints Dennis Raefield as Chief Operating Officer
Viscount Announces Completion of $500,000 Private Placement
Earlier this morning, Cardium Therapeutics announced that its CEO will be presenting at the Biotech Showcase 2013 Conference. This year the annual conference is being held January 7-9 at the Parc 55 Wyndham San Francisco Union Square Hotel. Cardium’s presentation will be available live and by replay. Those unable to attend will be able to access the executive presentation at http://phx.corporate-ir.net/phoenix.zhtml?c=77949&p=irol-calendar.
Cardium will provide a corporate overview as well as a review of its entrepreneurial initiatives, which include strategic partner-enabled product and platform opportunities that have been internally developed based on Cardium’s unique skill set, capabilities, and technology.
Current entrepreneurial initiatives include: (1) the clinical development of Genedexa™ (previously referred to as the Excellarate™ product candidate), a DNA-based Phase 2b/3 product candidate initially for the treatment of chronic, non-healing diabetic foot ulcers and representing the first product extension from Cardium’s FDA-cleared Excellagen® technology platform; (2) LifeAgain™, a medical analytics and e-commerce platform of algorithms and medical-based social media programs that were developed by Cardium researchers to support a strategically partnered commercialization of specialized survivable risk life insurance underwritings for cancer patients and patients with chronic medical diseases, based on the improvement of early diagnosis and new chronic treatments and curative medical therapies; and (3) plans to leverage the established infrastructure, distribution capabilities, and established retail network of To Go Brands® through internal product development, external product acquisitions, and strategic partnering.
In addition to the initiatives listed above, Cardium Therapeutics will continue to focus on its primary objectives that include: (1) the strategic partnering and commercialization of the FDA-cleared Excellagen® product and platform; and (2) the successful completion of the DNA-based Generx® Phase 3 development program. Information is provided in an updated investor presentation now available on Cardium’s website at http://phx.corporate-ir.net/phoenix.zhtml?c=77949&p=irol-presentations.
For more information on Cardium, visit www.CardiumTHX.com
Dennis Raefield, previously President of Honeywell Access Systems and then CEO of Mace Security, recently became the COO of Viscount Systems, a global provider of advanced facility access control systems. Raefield, who has an extensive background in the security industry, has served on the Viscount board.
At Honeywell Access Systems, a $100 million division of Honeywell International, Mr. Raefield was responsible for enterprise level access control systems for Fortune 100 clients. He was also the President of Pinkerton Systems Integration, currently Securitas, responsible for access control systems for Fortune 500 clients. Mr. Raefield was also CEO/owner of Omega Corporate Security, a California-based security system integration company.
Mr. Raefield is joining Viscount at a critical time in the security industry, when technology is moving away from its traditional control panel orientation to integrated IT-based systems. Mr. Raefield commented that Viscount’s “Freedom access control platform is the first and only system that allows entry devices and other building automation systems to be connected to standard building IT networks without requiring expensive control panels that are programmed from a PC,” describing how their system “connects the card reader and door strike through the Internet.” The system uses logical IT security software, such as Microsoft’s Active Directory, to replace control panels and traditional software components. There’s no need for a separate database or security infrastructure, making integrated security simpler, stronger, and more cost effective.
Viscount is a leading driver of the new approach, and the company has been successful in its moves to raise funds to expand development and their sales force. Viscount currently has access control systems or equipment installed at thousands of sites throughout the world, and anticipates significant growth as the new technology dominates the industry.
For more information on Viscount Systems and its cutting-edge technologies, visit www.Viscount.com
Inergetics, the nutritional supplement developer for the growing clinical health and sports supplement markets, reported today that the company has appointed award-winning outdoor advertising and marketing firm, AR James Media, Inc., founder, president, and CEO, James DeLucia, to the company’s Board.
DeLucia brings an impressive track record to the company, having cut his teeth on the floor of the New York Mercantile Exchange in the late 80′s, before going on to form ALX Energy, Inc., after holding membership in two divisions on the COMEX (1992) and NYMEX (1999). The experience garnered at AR James Media by DeLucia, which specializes in various “out-of-home” advertising mediums like transit shelters and junior billboards (even large format and digital venues), will serve NRTI shareholders well as the company continues to move the ball down the field with their lean muscle-building, clinically studied performance enhancing product, Surgex® sports nutrition formula, as well as the company’s full, upcoming product lineup.
DeLucia has also been providing overwatch in the state and municipal programs at AR James Media, which includes the kind of public bidding and relationship management activities that brought him directly into contact with government officials on a continuous basis, something which yet again proves he has the sort of inter-personal management skills the Board needs to knock it out of the park during the 2013 mass market brand push. DeLucia’s AR James Media firm owns and operates some 1k plus billboards throughout the New York/New Jersey metro market and is in a good position to deliver direct consumer engagement metrics, with time-tested and proven advertising infrastructure.
Given the status of ALX Energy as the premier brokerage services provider in futures and options for many top banks, hedge funds, utilities, and the like, it is clear the DeLucia also has the kind of in-depth knowledge of the finance end of things required to produce serious operational results at NRTI. Results like his having led ALX to obtaining the record for most volume in the Natural Gas prop month close ever executed in the entire history of the contract.
CEO and CFO of NRTI, Mike James, cited DeLucia’s exemplary performance as President and CEO of two successful start-ups, in addition to his obviously vast experience in the trenches of the advertising industry, as being ideally suited to the task of helping to take the Inergetics portfolio of brands to the next level.
With NRTI making the big push into mass markets, it is going to be quite handy indeed to have someone like DeLucia, with his boots-on-the-ground advertising know-how on the Board. 2013 could be huge for NRTI as the company moves to kick open a broader retail distribution door and bring a whole array of consumer brands, developed by the company to meet the exacting needs of highly active people, to a rapidly growing consumer segment.
To learn more about Inergetics, please visit www.Inergetics.com
New Western Energy Corp., an independent energy company engaged in the acquisition, exploration, development, and production of oil, gas, and minerals primarily in North America, recently announced the completion of its acquisition of 8 oil and gas leases, which total 1,520 acres, with 106 oil wells and 8 disposal wells in Rogers County, OK. New Western purchased the leases from Pioneer Oil Development LLC.
In addition to providing the development funds necessary to bring in to production the existing wells, New Western has stated that it intends to begin drilling additional wells upon completion of the workovers. The leases provide New Western with 950 contiguous acres, of which a full 640 acre section has been shown to provide open drilling opportunities with proven oil and gas formations. The leased acreage provides an already completed infra-structure that the company plans to use to serve its future gas production plans.
Javan Khazali, President and CEO of New Western Energy Corp, stated, “Completing these lease acquisitions furthers our strategic footprint in the highly productive region of Rogers County, OK, adding to our existing 80 acre Glass Lease and our 180 acre Phillips Lease. We are continuing to execute on our strategy of aggressively acquiring performing assets that are underdeveloped and will drive our growth in production.”
Bartlesville Sands will act as the initial target formation for New Western’s acquisition, corresponding with the company’s current efforts in the area. New Western has stated that its development plan has three phases: developing and implementing a well refurbishment plan for the newly acquired wells; expanding its geology work and structure mapping of the area so as to maximize its reservoir pressure maintenance program, which would consist of basic water flood programs; and lastly, laying out a strategic drilling program that follows the company’s structure mapping and formation development program.
Rogers County rests in the Central Oklahoma platform. Located north of Rogers County, the Central Oklahoma platform merges with the Cherokee basin of southeastern Kansas, where some of the first commercial oil discoveries for the mid-continent region were made. Similar to the Cherokee basin, the northern part of this district places emphasis on Cherokee (Pennsylvanian) sand reservoirs. The strata in this region dip westward, providing deeper reservoirs from east to west. South of the Central Oklahoma platform, the majority of production comes from pre-Pennsylvanian reservoirs. All of these reservoirs are located in New Western’s leased area.
For more information on New Western Energy Corp., visit www.NewWesternEnergy.com
Today's Top 3
Wall Street Resources
The QualityStocks Public Company Sponsor News
- Get profiles for new featured companies at clients.qualitystocks.net
- Advaxis, Inc. (ADXS) Appoints Daniel J. O'Connor to Senior Vice President, Chief Legal and Business Development Officer
- Bergamo Acquisition Corp. (BGMO) Achieves Current Information Status on OTC Markets
- Consorteum Holdings, Inc. (CSRH) Files Form 10-K Report With the Securities and Exchange Commission
- Cardium Therapeutics, Inc. (CXM) To Present At Biotech Showcase 2013 Investment Conference And Report On New Cardium Initiatives
- The Guitammer Company Inc. (GTMM) Insiders Acquire An Aggregate Of 156,000 GTMM Shares In Open Market Purchases
- GlobalWise Investments, Inc. (GWIV) Announces Board Changes
- International Stem Cell Corp. (ISCO) to Participate in Biotech Showcase 2013 on January 7th
- Loans4Less.com, Inc. (LFLS) Reports Financial Results for the Third Quarter of 2012
- TNI BioTech Inc. (TNIB) to Present at 6th Annual OneMedForum San Francisco 2013
- Viaspace, Inc. (VSPC) CEO Invited to Speak At EUEC2013 Conference and Company to Feature GiantKing™ Grass in Exhibit Hall
- Viscount Systems, Inc. (VSYS) SoundView Technology Group Issues Research Report
- VistaGen Therapeutics, Inc. (VSTA) Becomes Member of Centre for Commercialization of Regenerative Medicine Consortium